JETEMA Co. Ltd
JETEMA, Co., Ltd., a bio venture company, engages in the research and development of medicines and medical devices. It offers clostridium botulinum toxins, fillers, lifting threads for medical treatment, elastin and collagen stimulate solution under Ecolla, and healthy skin care under vitten brand names. The company also provides skin care hyaluronic acid masks. JETEMA, Co., Ltd. was founded in 2… Read more
JETEMA Co. Ltd - Asset Resilience Ratio
JETEMA Co. Ltd (216080) has an Asset Resilience Ratio of 0.10% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2024)
This chart shows how JETEMA Co. Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down JETEMA Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩223.61 Million | 0.1% |
| Total Liquid Assets | ₩223.61 Million | 0.10% |
Asset Resilience Insights
- Limited Liquidity: JETEMA Co. Ltd maintains only 0.10% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
JETEMA Co. Ltd Industry Peers by Asset Resilience Ratio
Compare JETEMA Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
OJsys Inc
PINK:OJSY |
Medical Instruments & Supplies | 0.00% |
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931 |
Medical Instruments & Supplies | 0.06% |
|
Blue Sail Medical Co Ltd
SHE:002382 |
Medical Instruments & Supplies | 5.12% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 35.75% |
|
Allmed Medical Products Co Ltd Class A
SHE:002950 |
Medical Instruments & Supplies | 3.78% |
|
Inix Technologies Holdings Bhd
KLSE:0094 |
Medical Instruments & Supplies | 0.06% |
|
Focus Point Holdings Bhd
KLSE:0157 |
Medical Instruments & Supplies | 2.30% |
|
Careplus Group Bhd
KLSE:0163 |
Medical Instruments & Supplies | 4.91% |
Annual Asset Resilience Ratio for JETEMA Co. Ltd (2017–2024)
The table below shows the annual Asset Resilience Ratio data for JETEMA Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 10.80% | ₩24.05 Billion | ₩222.72 Billion | -8.21pp |
| 2023-12-31 | 19.01% | ₩46.42 Billion | ₩244.23 Billion | +7.82pp |
| 2022-12-31 | 11.19% | ₩21.07 Billion | ₩188.35 Billion | -39.94pp |
| 2021-12-31 | 51.13% | ₩75.63 Billion | ₩147.93 Billion | +25.68pp |
| 2020-12-31 | 25.44% | ₩17.01 Billion | ₩66.86 Billion | +9.33pp |
| 2019-12-31 | 16.12% | ₩10.04 Billion | ₩62.29 Billion | -11.20pp |
| 2018-12-31 | 27.32% | ₩14.01 Billion | ₩51.29 Billion | +17.49pp |
| 2017-12-31 | 9.83% | ₩1.86 Billion | ₩18.97 Billion | -- |